FLNA Filana Therapeutics, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 29, 2026
$0.93
· of 52w range
· above low
· to high
$0.6752w low
$1.8052w high
Market Cap (MRQ)
$45M
EPS
$-1.88
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$6
P/E
·
ROE
-112.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
FLNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.93
Market Cap (MRQ)
$45M
EPS
$-1.88
ROE
-112.1%
52W Range
$1–$2
FLNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 10, 2017 | 1-for-7 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-1.882022-12-31 → 2025-12-31
Free Cash Flow$-33M2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | FLNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.7 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | FLNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -66.0%5Y avg ≈-36.1% | ≈-36.1% | · | · | |
| ROE | -112.1%5Y avg ≈-48.5% | ≈-48.5% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | FLNA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.15Y avg ≈14.5 | ≈14.5 | · | · | |
| Quick Ratio | 2.25Y avg ≈13.7 | ≈13.7 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$5.25
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Dec 13, 2012 | $5.25 | USD | — |
| Dec 13, 2010 | $14.00 | USD | — |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
23.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2025 | $-0.22 | $-0.28 | 20.1% | |
| March 31, 2025 | $-0.48 | — | — | |
| Dec. 31, 2024 | $-0.57 | $-0.67 | 14.7% | |
| Sept. 30, 2024 | $-0.58 | $-0.90 | 35.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $27M | $70M | $89M | $68M | $25M | · | · | $3M | $8M | $9M | $9M | $7M | |
| SG&A Expense | $69M | $72M | $17M | $12M | $8M | $4M | $3M | $4M | $4M | $6M | $5M | $5M | |
| Operating Expenses | $95M | $141M | $106M | $80M | $33M | $6M | $5M | $7M | $12M | $15M | $14M | $12M | |
| Operating Income | $-95M | $-141M | $-106M | $-80M | $-33M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M | |
| Other Non-op | $-203.0K | $411.0K | $907.0K | $997.0K | $434.0K | · | · | · | · | · | · | · | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-14M | $-12M | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-91M | $-24M | $-97M | $-76M | $-32M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M | |
| EPS (Basic) | $-1.88 | $-0.53 | $-2.32 | $-1.90 | $-0.82 | · | · | · | · | · | $-0.31 | $-0.27 | |
| EPS (Diluted) | $-1.88 | $-1.46 | $-2.32 | $-1.90 | · | · | · | · | · | · | $-0.31 | $-0.27 | |
| Shares (Basic) | 48,297,000 | 46,329,000 | 41,932,000 | 40,202,000 | 39,405,000 | · | · | · | · | · | 45,756,000 | 45,269,000 | |
| Shares (Diluted) | 48,297,000 | 46,604,000 | 41,932,000 | 40,202,000 | · | · | · | · | · | · | 45,756,000 | 45,269,000 | |
| EBITDA | $-95M | $-141M | $-106M | $-80M | $-33M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $129M | $121M | $201M | $233M | $94M | $23M | $20M | $10M | $17M | $31M | $41M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $2M | · | · | |
| Prepaid Expense | $2M | $8M | $8M | $10M | $11M | $488.0K | $268.0K | · | · | · | · | · | |
| Other Current Assets | $64.0K | $38.0K | $287.0K | $160.0K | · | $488.0K | $268.0K | $233.0K | $184.0K | $356.0K | $392.0K | $239.0K | |
| Current Assets | $98M | $137M | $130M | $211M | $244M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| PP&E (Net) | $21M | $21M | $22M | $23M | $21M | $11.0K | $47.0K | $87.0K | $156.0K | $232.0K | $215.0K | $65.0K | |
| PP&E (Gross) | $25M | $24M | $24M | $24M | $21M | $97.0K | · | · | · | · | · | · | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $396.0K | $86.0K | $900.0K | $900.0K | $800.0K | $700.0K | $700.0K | $600.0K | |
| Intangibles | $193.0K | $37.0K | $176.0K | $622.0K | $1M | · | · | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | $399.0K | · | · | $12.0K | $12.0K | · | $12.0K | $12.0K | |
| Total Assets | $118M | $158M | $152M | $235M | $267M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| Accounts Payable | · | · | · | $4M | $7M | $911.0K | $453.0K | $294.0K | $424.0K | $303.0K | $1M | $173.0K | |
| Accrued Liabilities | · | · | · | $2M | $3M | $719.0K | $777.0K | $156.0K | $399.0K | $27.0K | $894.0K | $25.0K | |
| Current Liabilities | $44M | $12M | $14M | $7M | $13M | $2M | $1M | $511.0K | $1M | $665.0K | $3M | $850.0K | |
| Capital Leases | · | · | $0 | $35.0K | $139.0K | $235.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | $118.0K | $79.0K | $0 | $197.0K | $194.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $44M | $12M | $14M | $7M | $13M | $2M | $1M | $511.0K | $1M | $665.0K | $3M | $850.0K | |
| Common Stock | $48.0K | $48.0K | $42.0K | $42.0K | $40.0K | $35.0K | $22.0K | $17.0K | $7.0K | $7.0K | $46.0K | $46.0K | |
| Paid-in Capital | $570M | $551M | $518M | $511M | $461M | $267M | $191M | $184M | $167M | $164M | $160M | $157M | |
| Retained Earnings | $-496M | $-405M | $-381M | $-284M | $-207M | $-175M | $-169M | $-164M | $-157M | $-145M | $-131M | $-116M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $1.0K | |
| Stockholders' Equity | $74M | $146M | $137M | $228M | $254M | $92M | $22M | $20M | $10M | $19M | $29M | $40M | |
| Liabilities + Equity | $118M | $158M | $152M | $235M | $267M | $94M | $23M | $20M | $11M | $19M | $32M | $41M | |
| Shares Outstanding | 48,307,896 | 48,203,179 | 42,236,919 | 41,735,557 | 40,016,792 | 35,237,987 | 21,841,810 | 17,219,300 | 6,595,509 | 6,591,705 | 45,756,117 | 45,756,117 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $22.0K | $58.0K | $69.0K | $68.0K | $58.0K | $45.0K | $15.0K | |
| Stock-based Comp | $20M | $16M | $5M | $2M | $2M | $988.0K | $1M | $2M | $3M | $4M | $3M | $4M | |
| Amort. of Intangibles | $33.0K | $180.0K | $446.0K | $497.0K | $224.0K | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | $-58.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-117M | $-82M | $-78M | $-30M | $-5M | $-3M | $-5M | $-8M | $-12M | $-9M | $-10M | |
| CapEx | $581.0K | $103.0K | $414.0K | $3M | $22M | · | $18.0K | · | · | $75.0K | $195.0K | $80.0K | |
| Investing Cash Flow | $-581.0K | $-103.0K | $-414.0K | $-3M | $-22M | $360.0K | $-18.0K | · | $2M | $-2M | · | · | |
| Stock Issued | · | $0 | $0 | $47M | $190M | $70M | · | $14M | · | · | · | $379.0K | |
| Net Stock Activity | · | $0 | $0 | $47M | $190M | · | · | $14M | · | · | · | $379.0K | |
| Financing Cash Flow | $-239.0K | $124M | $3M | $48M | $192M | $75M | $6M | $14M | · | $-284.0K | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $9M | $-6M | $-15M | $-9M | $-8M | |
| Free Cash Flow | $-33M | $-117M | $-82M | $-80M | $-52M | · | $-3M | · | · | $-12M | $-9M | $-10M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.0% | -15.8% | -50.3% | -30.4% | -17.9% | -10.8% | -21.2% | -42.3% | -79.1% | -58.0% | -38.9% | -27.2% | |
| ROE | -112.1% | -15.6% | -66.5% | -35.8% | -12.4% | -11.1% | -22.2% | -44.7% | -84.1% | -61.9% | -40.8% | -28.0% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 11.6 | 9.1 | 29.9 | 19.5 | 50.4 | 16.8 | 39.2 | 9.4 | 28.7 | 12.4 | 48.0 | |
| Quick Ratio | 2.2 | 10.9 | 8.5 | 28.5 | 18.6 | 50.1 | 16.6 | 38.8 | 9.3 | 28.1 | 12.3 | 47.8 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $3.02 | $3.25 | $5.45 | $6.35 | $2.62 | $1.01 | $1.14 | $1.47 | $0.40 | $0.64 | $0.88 | |
| Cash Flow / Share | $-0.67 | $-2.51 | · | · | · | · | · | · | · | · | $-0.20 | $-0.21 | |
| Cash / Share | $1.98 | $2.67 | $2.87 | $4.82 | $5.83 | $2.65 | $1.06 | $1.15 | $1.59 | $0.36 | $0.68 | $0.89 | |
| EPS (TTM) | $-1.88 | $-1.46 | $-2.32 | $-1.90 | $0.68 | $0.68 | $0.68 | $0.68 | $0.68 | $0.68 | $-0.31 | $-0.27 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | |
| Net Income TTM | $-91M | $-24M | $-97M | $-76M | $-32M | $-6M | $-5M | $-7M | $-12M | $-15M | $-14M | $-12M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $5M | $4M | $4M | $5M | $14M | $21M | $18M | $15M | $16M | $24M | $25M | $22M | $19M | · | · | |
| SG&A Expense | $6M | $7M | $10M | $8M | $40M | $11M | $9M | $13M | $46M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $9M | $11M | $14M | $12M | $45M | $25M | $29M | $31M | $61M | $20M | $28M | $29M | $27M | $21M | $20M | $18M | |
| Operating Income | $-9M | $-11M | $-14M | $-12M | $-45M | $-25M | $-29M | $-31M | $-61M | $-20M | $-28M | $-29M | $-27M | $-21M | $-20M | $-18M | |
| Other Non-op | $43.0K | $48.0K | $39.0K | $-114.0K | $-46.0K | $-82.0K | $90.0K | $62.0K | $99.0K | $160.0K | $223.0K | $203.0K | $190.0K | $210.0K | $275.0K | $263.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-9M | $-10M | $-13M | $-11M | $-44M | $-23M | $-28M | $-28M | $6M | $25M | $-26M | $-26M | $-24M | $-20M | $-19M | $-18M | |
| EPS (Basic) | $-0.18 | $-0.21 | $-0.26 | $-0.22 | $-0.92 | $-0.48 | $-0.66 | $-0.58 | $0.13 | $0.58 | $-0.61 | $-0.63 | $-0.58 | $-0.51 | $-0.48 | · | |
| EPS (Diluted) | · | · | $-0.26 | $-0.22 | $-0.92 | $-0.48 | $-0.58 | $-0.58 | $0.13 | $-0.43 | $-0.61 | $-0.63 | $-0.58 | · | $-0.48 | $-0.44 | |
| Shares (Basic) | · | · | · | 48,308,000 | 48,308,000 | 48,262,000 | · | 47,976,000 | 46,202,000 | 43,001,000 | 42,002,000 | 41,793,000 | 41,739,000 | 40,050,000 | 40,015,000 | · | |
| Shares (Diluted) | · | · | · | 48,308,000 | 48,308,000 | 48,262,000 | · | 47,976,000 | 46,202,000 | 44,102,000 | 42,002,000 | 41,793,000 | 41,739,000 | · | 40,015,000 | 39,962,000 | |
| EBITDA | $-9M | $-11M | · | $-12M | $-45M | $-25M | · | $-31M | $-61M | $-20M | $-28M | $-29M | $-27M | $-21M | $-20M | $-18M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $83M | $87M | $96M | $106M | $112M | $117M | $129M | $149M | $207M | $124M | $142M | $168M | $187M | $175M | $197M | $210M | |
| Prepaid Expense | $1M | $1M | $2M | $3M | $2M | $3M | $8M | $14M | $15M | $10M | $8M | $6M | $8M | $9M | $7M | $13M | |
| Other Current Assets | $198.0K | $220.0K | $64.0K | $106.0K | $134.0K | $162.0K | $38.0K | $192.0K | $161.0K | $218.0K | $189.0K | · | · | · | · | · | |
| Current Assets | $84M | $88M | $98M | $109M | $115M | $120M | $137M | $203M | $222M | $134M | $150M | $175M | $195M | $183M | $204M | $222M | |
| PP&E (Net) | $20M | $20M | $21M | $21M | $21M | $21M | $21M | $21M | $21M | $22M | $22M | $22M | $23M | $23M | $22M | $21M | |
| PP&E (Gross) | $25M | $25M | $25M | $25M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $24M | $23M | $21M | |
| Accum. Depreciation | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $929.0K | $748.0K | $574.0K | |
| Intangibles | · | · | $193.0K | · | · | · | $37.0K | $69.0K | $82.0K | $115.0K | $268.0K | $387.0K | $503.0K | $740.0K | $859.0K | $940.0K | |
| Total Assets | $104M | $108M | $118M | $130M | $135M | $141M | $158M | $224M | $244M | $156M | $173M | $197M | $218M | $207M | $227M | $244M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | $10M | $8M | $4M | $5M | $3M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $7M | $5M | $4M | $3M | $3M | |
| Current Liabilities | $40M | $40M | $44M | $48M | $47M | $13M | $12M | $57M | $55M | $77M | $17M | $18M | $14M | $8M | $9M | $7M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | · | · | $62.0K | $88.0K | $114.0K | |
| Other Non-current Liabilities | $136.0K | $111.0K | $118.0K | $119.0K | $79.0K | $79.0K | $79.0K | $80.0K | · | · | $0 | · | $197.0K | $197.0K | $201.0K | $194.0K | |
| Total Liabilities | $40M | $40M | $44M | $48M | $47M | $13M | $12M | $57M | · | · | $17M | $18M | $14M | $9M | $9M | $7M | |
| Common Stock | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $48.0K | $43.0K | $42.0K | $42.0K | $42.0K | $40.0K | $40.0K | $40.0K | |
| Paid-in Capital | $579M | $575M | $570M | $565M | $561M | $556M | $551M | $544M | $538M | $434M | $515M | $514M | $512M | $463M | $462M | $462M | |
| Retained Earnings | $-515M | $-506M | $-496M | $-484M | $-473M | $-429M | $-405M | $-378M | $-350M | $-356M | $-360M | $-334M | $-308M | $-264M | $-244M | $-225M | |
| Stockholders' Equity | $64M | $68M | $74M | $82M | $88M | $128M | $146M | $167M | $189M | $79M | $155M | $179M | $204M | $199M | $218M | $237M | |
| Liabilities + Equity | $104M | $108M | $118M | $130M | $135M | $141M | $158M | $224M | $244M | $156M | $173M | $197M | $218M | $207M | $227M | $244M | |
| Shares Outstanding | 48,307,896 | 48,307,896 | 48,307,896 | 48,307,896 | 48,307,896 | 48,307,896 | 48,203,179 | 47,976,166 | 47,976,166 | 43,248,416 | 42,129,798 | 41,919,527 | 41,749,435 | 40,059,514 | 40,097,917 | 40,031,280 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $6M | $3M | $2M | $949.0K | $835.0K | $673.0K | $470.0K | $485.0K | $495.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | $31.0K | $32.0K | $56.0K | $61.0K | $119.0K | $119.0K | $119.0K | $119.0K | $125.0K | $135.0K | |
| Operating Cash Flow | $-4M | $-9M | $-10M | $-6M | $-5M | $-11M | $-61M | $-18M | $-18M | $-19M | $-27M | $-20M | $-13M | $-22M | $-11M | $-24M | |
| CapEx | · | · | $501.0K | $80.0K | $0 | $0 | $57.0K | $17.0K | $29.0K | $0 | $22.0K | $-6.0K | $357.0K | $1M | $1M | $425.0K | |
| Investing Cash Flow | · | · | $-501.0K | $-80.0K | $0 | $0 | $-57.0K | $-17.0K | $-29.0K | $0 | $-22.0K | $6.0K | $-357.0K | $-1M | $-1M | $-425.0K | |
| Financing Cash Flow | $-16.0K | $-51.0K | $-329.0K | $0 | $0 | $90.0K | $918.0K | $0 | $101M | $22M | $464.0K | $889.0K | $64.0K | $136.0K | $119.0K | $211.0K | |
| Free Cash Flow | · | · | · | · | · | $-11M | · | · | · | $-19M | · | · | $-14M | · | · | $-24M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -7.2% | -8.3% | · | -6.1% | -23.3% | -15.8% | · | -14.1% | 2.8% | 13.4% | -13.5% | -12.4% | -10.5% | -8.4% | -7.6% | -6.6% | |
| ROE | -11.3% | -10.5% | · | -8.7% | -31.9% | -22.7% | · | -17.4% | 3.3% | 17.7% | -14.5% | -13.3% | -11.0% | -8.7% | -7.8% | -6.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.2 | · | 2.3 | 2.4 | 9.1 | · | 3.6 | 4.1 | 1.7 | 8.6 | 9.8 | 14.0 | 22.1 | 23.4 | 32.7 | |
| Quick Ratio | 2.1 | 2.2 | · | 2.2 | 2.4 | 8.9 | · | 2.6 | 3.8 | 1.6 | 8.2 | 9.4 | 13.5 | 21.0 | 22.6 | 30.9 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.32 | $1.41 | · | $1.69 | $1.82 | $2.64 | · | $3.47 | $3.94 | $1.82 | $3.68 | $4.28 | $4.89 | $4.96 | $5.45 | $5.92 | |
| Cash Flow / Share | · | · | · | · | · | $-0.23 | · | · | · | $-0.43 | · | · | $-0.32 | · | · | · | |
| Cash / Share | $1.71 | $1.79 | · | $2.20 | $2.33 | $2.43 | · | $3.11 | $4.32 | $2.87 | $3.38 | $4.02 | $4.49 | $4.36 | $4.92 | $5.24 | |
| EPS (TTM) | $-1.88 | $-1.88 | · | $-2.20 | $-2.56 | $-1.51 | · | $-1.38 | $-1.41 | $-2.17 | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $41M | · | $41M | $41M | $41M | · | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | $41M | |
| Net Income TTM | $-42M | $-78M | · | $-106M | $-123M | $-73M | · | $-18M | $-15M | $-48M | $-95M | $-90M | $-83M | $-71M | $-61M | $-46M | |
| Market Cap | $57M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 1.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -158.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-91M | $-24M | $-97M | $-76M | $-32M |
| Diluted EPS | $-1.88 | $-1.46 | $-2.32 | $-1.90 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.2 | 11.6 | 9.1 | 29.9 | 19.5 |
| Quick Ratio | 2.2 | 10.9 | 8.5 | 28.5 | 18.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-33M | $-117M | $-82M | $-80M | $-52M |
Institutional owners (13F) 2 filers · $48 total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
2
Value held
$48
New positions
0
Exited positions
0
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-1 vs prior Q) | 0 (0 vs prior Q) | 0 (0 vs prior Q) | 0 (0 vs prior Q) | -251K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Byrne Asset Management LLC | $48 | 40 | 100.00% | Shares |
| TANAKA CAPITAL MANAGEMENT INC | $0 | 251,150 | 0.00% | Shares |
Company insiders 22 insiders · 10 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Richard Barry | President & CEO | Sept. 30, 2026 P | 1,337,964 | 5 | 0 | $972,137 |
| Remi Barbier | President & CEO | May 20, 2024 A | 734,279 | 0 | 0 | $0 |
| Eric Schoen | Chief Financial Officer | April 17, 2025 A | 11,500 | 0 | 0 | $0 |
| Peter S Roddy | Chief Financial Officer | April 8, 2016 A | 121,479 | 0 | 0 | $0 |
| Robert Christopher Cook | Chief Operating & Legal Office | Sept. 30, 2025 P | 13,725 | 0 | 0 | $0 |
| Freda Nassif | Chief Business Officer | April 17, 2025 A | · | 0 | 0 | $0 |
| James William Kupiec | Chief Medical Officer | Nov. 29, 2024 S | 0 | 0 | 0 | $0 |
| Jaren Landen | Chief Clinical Dev. Officer | Nov. 18, 2024 A | · | 0 | 0 | $0 |
| Nadav Friedmann | Chief Medical Officer | Oct. 3, 2022 M | 79,910 | 0 | 0 | $0 |
| Grant Schoenhard | Chief Scientific Officer | July 11, 2014 M | 78,551 | 0 | 0 | $0 |
| Robert Eugene Anderson Jr | Director | Nov. 24, 2025 P | 8,600 | 1 | 0 | $24,940 |
| Dawn Carter Bir | Director | Oct. 21, 2025 A | · | 0 | 0 | $0 |
| Pierre Gravier | Director | May 23, 2025 A | · | 0 | 0 | $0 |
| Claude Nicaise | Director | May 23, 2025 A | · | 0 | 0 | $0 |
| Donnell Michael J O | Director | May 23, 2025 A | 6,873 | 0 | 0 | $0 |
| Robert Z Gussin | Director | May 23, 2025 A | 10,617 | 0 | 0 | $0 |
| Patrick J Scannon MD PHD | Director | May 23, 2025 A | 1,000 | 0 | 0 | $0 |
| Sanford Robertson | Director | May 16, 2024 G | 5,000 | 0 | 0 | $0 |
| Saira Ramasastry | Director | Dec. 13, 2019 A | · | 0 | 0 | $0 |
| EASTBOURNE CAPITAL MANAGEMENT LLC/CA | 10% owner | Sept. 29, 2009 S | 3,230,204 | 0 | 0 | $0 |
| BLACK BEAR OFFSHORE MASTER FUND LP | 10% owner | July 1, 2009 J | 4,186,238 | 0 | 0 | $0 |
| Vernon R Loucks JR | · | Sept. 21, 2007 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
FLNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$6.50
+598.2%
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-28Mean target $6.50 +598.2%
← Below all targets
Current price $0.93
Low$5.00
Mean$6.50
High$8.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 29, 2026